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Abstract The ubiquinol :cytochrome c oxidoreductase (EC
1.20.2.2, QCR or cytochrome bc1 complex) is a component of
respiratory and photosynthetic electron transfer chains in
mitochondria and bacteria. The complex transfers electrons
from quinol to cytochrome c. Electron transfer is coupled to
proton translocation across the lipid bilayer, thereby generating
an electrochemical proton gradient, which conserves the free
energy of the redox reaction. The yeast complex was crystallized
with antibody Fv fragments, a promising technique to obtain
well-ordered crystals from membrane proteins. The high-resolu-
tion structure of the yeast protein reveals details of the catalytic
sites of the complex, which are important for electron and proton
transfer. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Ubiquinol:cytochrome c oxidoreductase (QCR) belongs to
a large family of cytochrome bc complexes, which are integral
membrane proteins that serve as central components of the
energy conversion machinery of photosynthesis and respira-
tion in chloroplasts, mitochondria, and bacteria [1,2]. These
multisubunit complexes couple electron transfer reactions to
proton translocation across a membrane and thereby conserve
the free energy of the redox reactions in an electrochemical
proton gradient. The latter is utilized to drive energy-depen-
dent processes like ATP synthesis or secondary transport.
Mitochondrial QCR catalyses electron transfer from ubi-
quinol to cytochrome c (CYC).
QH2  2CYCFe3  2Hi ! Q 2CYCFe2  4Ho
The quinol mediated energy conversion is depicted in Fig. 1.
Ubiquinol (QH2) oxidation takes place at the Qo site and
involves a bifurcated electron transfer. One electron is trans-
ferred via the Fe2S2 iron^sulfur centre to haem c1, the electron
donor for cytochrome c reduction. The second electron is used
to reduce ubiquinone (Q) bound at the Qi site, thereby gen-
erating a relatively stable semiquinone. The latter is fully re-
duced to quinol after oxidation of a second quinol molecule at
the Qo site. Protons are taken up from the matrix side upon
quinone reduction and released to the intermembrane space
during quinol oxidation. The hydrophobic substrates quinol
and quinone can freely di¡use within the phospholipid bi-
layer. This mechanism, known as Q cycle, facilitates proton
translocation, thereby contributing to the generation of a pro-
ton gradient [3,4].
In the last few years, structures of vertebrate and yeast
QCRs have become available [5^8], a breakthrough in under-
standing the enzyme mechanism and structure^function rela-
tionships. The 2.3 Aî resolution structure of yeast QCR is the
atomic structure of highest resolution available so far [8]. It
allowed a detailed description of substrate- and inhibitor-
binding sites, elucidating parts of the enzyme mechanism
and suggesting pathways for proton transfer. Yeast QCR
was crystallized with the help of antibody fragments. This
approach appears to be of general importance for the crystal-
lization of membrane proteins and will be outlined. In addi-
tion, some aspects of the structure^function relationship will
be described here (for detailed reviews see [1^4,9]).
2. Crystallization of membrane proteins with
antibody fragments
High-resolution structures of proteins provide valuable in-
formation to understand the mechanism of enzymes as well as
for rational drug design. An excellent tool to obtain these
structures is X-ray crystallography that requires well-ordered
three-dimensional crystals as prerequisite. Three-dimensional
crystallization of membrane proteins is hampered by the fact
that these proteins have to be used in solubilized form. For
this purpose their transmembrane portion, which in vivo re-
sides in the phospholipid bilayer, is covered by a detergent
micelle. Crystal formation is highly dependent on crystal con-
tacts between surfaces of the hydrophilic protein domains,
which are exposed to the bulk solvent [10^13]. In some fam-
ilies of membrane proteins, e.g. channels and transporters, the
hydrophilic domains may be very small. A strategy to improve
the likelihood of successful crystallization is to enlarge the
hydrophilic surface of membrane proteins by surface expan-
sion. This can be achieved by binding antibody fragments to
the membrane protein, an approach that was successfully in-
troduced by Michel and colleagues. They crystallized and de-
termined the structure of the cytochrome c oxidase from Para-
coccus denitri¢cans [14,15] and of a fragment of this protein
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[16]. The structure of the yeast QCR was the third successful
example for this technique [8].
Antibody fragments are well suited for this approach as
they form a stable, rigid interaction with the antigen, thereby
avoiding the introduction of £exible regions, which are in
general an obstacle for crystallization. To ensure a stable as-
sociated ‘domain’, the selected antibody should not only bind
to the native protein but should preferentially recognize a
discontinuous epitope. A modi¢cation of the size of the do-
main is possible by using either Fv fragments (V28 kDa) or
Fab fragments (V56 kDa). Furthermore, antibody fragments
could be used to stabilize speci¢c conformations of the protein
to aid crystallization attempts. Three-dimensional crystalliza-
tion of complex target antigens, such as viral £exible proteins,
has been achieved with speci¢cally bound Fab fragments [17].
Speci¢cally tailored screening strategies are the key step in
selecting suitable antibodies from hybridoma fusions or re-
combinant libraries. The introduction of an enzyme linked
immunosorbent assay based on a nickel chelating matrix al-
lows the presentation of native, detergent solubilized mem-
brane protein via a histidine a⁄nity tag. This method pro-
vided monoclonal antibodies exclusively against the native
sodium/proton antiporter NhaA from Escherichia coli [18], a
12 transmembrane protein with very short solvent exposed
loops. These antibodies were used to probe conformational
changes of the antiporter upon regulatory pH shift [19].
Fab fragments produced by proteolytic digestion have been
successfully used for crystallization [17]. Antibody fragments
can be obtained by cloning the respective genes starting from
hybridoma cell lines [20,21]. A variety of expression systems
are used for the production of the fragments, including peri-
plasmic expression in E. coli [20]. Alternatively, direct selec-
tion of recombinant antibody fragments from phage display
libraries is well established [22,23] and a new approach to
select antibodies from libraries evolved by ribosome display
seems to be promising [24]. Recombinant fragments are ver-
satile tools, providing for instance the introduction of fused
a⁄nity tags, so that they can be used for one-step puri¢cation
of antigen^antibody complexes without the need to engineer
the target protein [20].
Yeast QCR was crystallized with the help of an Fv frag-
ment derived from the mAB18E11 [8]. The Fv fragment binds
to the extrinsic domain of the iron^sulfur protein and pro-
vides generous space for the detergent micelle in the crystal
packing (Fig. 2) [8]. It is found to be essential for the packing
by mediating the crystal contacts.
3. Overall structure of QCR
The mitochondrial QCR is present as an intertwined homo-
dimer (Figs. 1 and 2). In general, there is good overall homol-
ogy of the vertebrate and yeast QCR structures. The centre of
the complex is formed per monomer by eight transmembrane
helices of cytochrome b, and attached to these central domain
are the single transmembrane anchors of the Rieske protein
and cytochrome c1, the two other catalytic subunits. The ex-
trinsic domains of the latter are located in the intermembrane
space. On the same side of the membrane, QCR6 or the so-
called hinge protein is bound. The homologue subunit of the
bovine complex was shown to be important for cytochrome c
binding [25]. Single transmembrane helices of subunits QCR8
and QCR9 are attached at the periphery of the catalytic core.
In bovine QCR a third small, single transmembrane subunit is
present [7]. It is a homologue of QCR10, a loosely associated
subunit of the yeast complex, which is not present in the
structure [8]. Interestingly, phospholipid molecules that are
tightly bound within the transmembrane region are found in
the structure of yeast QCR. Their well-de¢ned binding sites
suggest speci¢c roles in assembly and function of the complex
(Hunte et al., in prep.). The matrix portion of the complex is
formed by two large subunits, COR1 and QCR2, the so-called
core proteins, and by QCR7. The core proteins have high
sequence similarity with soluble, matrix processing peptidases
and are thought to be evolutionarily related to these Zn-bind-
ing proteases [26]. Core proteins do not have proteolytic ac-
tivity in most species, with the exception of plants [26]. How-
ever, a biochemical study suggested residual proteolytic
activity in bovine QCR [27]. Furthermore, the cleaved signal
sequence of the Rieske protein is part of the bovine complex
and is named subunit 11. The peptide is bound in a cleft
between the core proteins and it has been speculated that
the core proteins are active in processing the precursor [7].
Interestingly, structural comparison of bovine core protein 1
with the Zn-dependent protease thermolysin, which was per-
formed by applying a reverse N-to-C orientation, demon-
strated a striking similarity of the overall structural architec-
ture and of the catalytic site of thermolysin and its proposed
counterpart in the core protein, suggesting a structure^func-
tion convergence of these proteins [28] and supporting the
close relation of core proteins with Zn-binding proteases.
4. Enzyme mechanism
The catalytic centre of the enzyme consists of cytochrome b
with two non-covalently attached haem b groups, the Rieske
Fig. 1. Structural model of the dimeric yeast QCR and schematic
representation of the Q cycle within a functional unit. Electron
transfer from quinol to the acceptor cytochrome c is coupled to
proton translocation. Electron transfer is indicated with white ar-
rows, proton translocation in green. The bifurcated electron transfer
upon quinol oxidation is highlighted in orange. The sites of quinol
oxidation (Qo site) and quinone reduction (Qi site) are indicated.
Cofactors are labelled as follows: FeS, Fe2^S2 cluster; bL, haem
bL ; bH, haem bH ; c1, haem c1 ; c, haem c. Matrix, inner membrane
and intermembrane space are indicated with MA, IM, IMS, respec-
tively. The complex consists per monomer of nine subunits (repre-
sented as ribbon drawings), cytochrome b (red), Rieske protein
(green), cytochrome c1 (yellow) and their respective cofactors, the
core proteins 1 (blue) and 2 (purple), and the small subunits QCR6
(cyan), QCR7 (faint purple), QCR8 (dark blue), and QCR9 (grey).
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protein with a Fe2S2 iron^sulfur centre, and cytochrome c1
with a covalently attached haem c group (Fig. 3A,B). The
enzyme is a functional dimer, it has two sites for quinol ox-
idation, for quinone reduction and most likely for cytochrome
c binding. Each Qo site is constructed by the catalytic domains
of cytochrome b and cytochrome c1 of one monomer and the
Rieske protein of the second monomer, to which the latter
subunit is bound with its transmembrane anchor. Monomer-
ization of the complex would disrupt the integrity of the site
of quinol oxidation, the catalytic centre of the complex. Dis-
tances and arrangements of the cofactors obviously allow fast
electron transfer within a functional unit (Fig. 3C) [5^8].
Whether the catalytic reactions of the two functional units
are coordinated or whether they operate independently is a
matter of debate [2,5,9,29].
One of the striking features of the ¢rst QCR structures was
the ¢nding that the extrinsic domain of the Rieske protein is
mobile. The domain was not resolved in the ¢rst structure [5]
and found in di¡erent orientations in the second [6]. It seems
that the domain has to be ¢xed either by inhibitor binding or
crystal contacts to be seen in a crystal structure. The move-
ment of the Rieske domain facilitates the transfer of the iron^
sulfur cluster from a position close to haem bL to a position
close to haem c1 (Fig. 3C). The resulting orientations of the
cofactors are well suited for electron transfer, indicating that
the mobile domain shuttles electrons between cytochrome b
and cytochrome c1 [6]. The extrinsic domain is connected with
the transmembrane anchor by a £exible linker region. Mod-
i¢cations in the linker region, which shorten, elongate or in-
crease rigidity of the linker, are deleterious for the enzyme
activity, supporting the view that the mobility of the extrinsic
domain is essential [2,30,31]. In the yeast QCR structure the
linker is stretched out in the most extended position, but the
initial part of the linker forms a 310-helix that is stabilized by
hydrogen bonds with neighbouring residues of cytochrome b.
The linker has to wind up when the extrinsic Rieske domain
swings towards cytochrome c1 [6,7] and it is likely that
the ¢rst helical turn forms a matrix to direct the coiling of
the helix [31]. A steered molecular dynamics simulation
has shown that the movement between di¡erent positions
of the mobile domain found in crystal structures is feasible
[32]. Additionally, there is some evidence that the orienta-
tion of the domain is related to redox condition as shown
by EPR [33]. However, the actual mechanism underlying
this functionally important domain movement is still un-
known [2].
5. Quinone reduction
Quinone reduction takes place at the Qi site. The binding
mode of the natural substrate coenzyme Q6 in this site was
described for the yeast QCR structure [8]. The molecule is
bound in a hydrophobic pocket, which is accessible from hy-
drophobic clefts present at each side of the dimer interface in
the transmembrane region. The quinone head group is bound
close to haem bH. Its orientation is stabilized by hydrophobic
Fig. 2. Essential crystal contacts (white arrows) of the dimeric yeast QCR^Fv fragment complex are mediated by the Fv fragment (encircled in
red). The fragment binds to the extrinsic domain of the Rieske protein and generously provides space for the detergent micelle, in which the
transmembrane portion of the complex (dotted lines) is embedded, as schematically depicted in the insert. The central molecule of the crystal
packing is coloured in green and yellow, the neighbouring molecules in grey.
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interactions with Met221 of cytochrome b and the bend pro-
pionate A of haem bH (Fig. 4A). Direct and indirect polar
interactions are found between side chain atoms of His202,
Asp229 and Ser206 of cytochrome b and the oxygen atoms of
the quinone carbonyl groups (Fig. 4B). Mutational studies
have shown that these three residues are critical for enzyme
activity [34^36]. However, the oxygen atoms of the quinone
carbonyl groups are in closest contact with water molecules,
suggesting that these water molecules act as primary proton
donors during quinone reduction and protons are consecu-
tively replenished by His202 and Asp229. These residues are
connected with the bulk solvent, either directly or by a short
array of hydrogen-bonded, buried water molecules [8]. The
symmetrical and perpendicular orientation of the quinone
ring plane to the plane of the haem porphyrin ring and the
existence of two presumable proton donors suggest that the
Fig. 3. QCR is a functional dimer. A: Catalytic subunits of yeast QCR. The subunits of one functional unit are colour coded: cytochrome b,
orange; Rieske protein, green; cytochrome c1, yellow. The second functional unit is coloured in grey. B: Schematic representation of one func-
tional subunit. The Rieske protein is anchored with its transmembrane helix in one monomer, while the extrinsic domain forms a functional
unit with the catalytic subunits of the other monomer. Qo sites are depicted as diamonds, Qi sites as circles. C: Orientation of cofactors, sub-
strate and inhibitor molecules in yeast QCR. Monomer A and B are colour coded in red and blue, respectively. The extrinsic domain of the
Rieske protein is mobile and the Fe2^S2 cluster can be found in di¡erent orientations with the maximal positions either close to haem bL (b-po-
sition) or close to haem c1 (c-position). The latter orientation is found in a bovine QCR structure (X, PDB entry: 1BE3) and the Fe2^S2 cluster
of the superimposed model is coloured in green. In yeast stigmatellin speci¢cally binds to the Qo site stabilizing the b-position and inhibiting
enzyme activity. Electron transfer and proton uptake are indicated with straight arrows. The curved arrow represents the movement of the
Fe2^S2 cluster, which most likely precedes oxidation of the cluster by cytochrome c1. The spatial arrangement of the cofactors allows fast elec-
tron transfer.
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two-electron and two-proton reduction of quinone can take
place without major reorientation of the molecule.
6. Quinol oxidation
The site of quinol oxidation is located close to haem bL and
is formed by cytochrome b and the mobile extrinsic domain of
the Rieske protein. There is considerable debate whether qui-
nol oxidation requires either one or two quinol molecules
bound at the Qo site, as suggested by the single- [37] or dou-
ble-occupancy model [38]. Up to now, none of the available
native structures showed quinol bound at this site. The Qo
binding pocket is bifurcated and di¡erent classes of Qo site-
speci¢c inhibitors are found to occupy two di¡erent domains
of the pocket [5^9,37,39]. However, this can be interpreted
either in favour of or against the double-occupancy model,
as the two domains are overlapping. Despite the large number
of di¡erent spectroscopic and genetic experiments, no conclu-
sive decision in support of one of the models can be taken [2].
Further experiments are required to clarify the important
question of Qo site occupancy.
In the structure of yeast QCR the inhibitor stigmatellin is
bound in the Qo site. Binding of stigmatellin is stabilized by
two hydrogen bonds: (1) between the oxygen atom of the
carbonyl group of stigmatellin and the O-nitrogen atom of
His181 of the Rieske protein, a ligand of the Fe2^S2 cluster,
and (2) between the hydroxyl group of stigmatellin and the
side chain of Glu272 of cytochrome b (Fig. 5). Thereby, the
mobile Rieske domain is ¢xed in the so-called b-position,
close to haem bL. It seems likely that the binding mode of
stigmatellin resembles that of a quinol oxidation intermediate
as shown for the QB site of the reaction centre from Rhodo-
pseudomonas viridis [8,40] and that the two residues help to
stabilize the enzyme^substrate complex. Mutagenesis of the
conserved glutamate results in reduction or loss of quinol
oxidation [36], supporting the importance of the residue for
the mechanism. The binding of stigmatellin is in agreement
with the following basic steps of a quinol oxidation model
[2,8,37]. The ¢rst electron is transferred to the Fe2^S2 cluster,
which will be oxidized by haem c1 after movement of the
Rieske domain to the c-position. The second electron reduces
haem bL and two protons are released upon oxidation. It is
noteworthy that the binding of the cluster bearing tip of the
Rieske protein in the b-position results in a tight interaction
of the surfaces of the two interacting subunits, thus excluding
access to the bulk solvent [8]. Primary proton acceptors dur-
ing quinol oxidation are most likely His181 of the Rieske
protein and Glu272. The side chain of the latter residue is
found in an alternate position in QCR structures with an
empty quinol binding pocket [6,7]. It was suggested that the
movement of this residue towards an array of buried water
molecules connected by hydrogen bonds facilitates a proton
exit pathway [8,37]. Suitable water molecules are present in
the high-resolution structure of yeast QCR. They are located
between the propionate groups of haem bL and the presum-
able quinol oxidation site (Fig. 5). Directing the proton to-
wards the haem parallel to the electron transfer might be
advantageous for electrostatic reasons, as charge compensa-
tion could speed up proton transfer. Release of protons from
His181 may take place from the bulk solvent during move-
ment of the Rieske domain to the c-position. There is no
consensus about intermediate steps of quinol oxidation. An
initial study showed the presence of a transient semiquinone
at the Qo site suggesting a sequential mechanism for the two
electron transfer steps [41]. Recent studies demonstrated that
a semiquinone radical is not detectable [42], favouring a con-
certed oxidation of quinol by cytochrome b and the Rieske
protein [43,44] or a sequential mechanism that includes a ro-
tation of the semiquinone to facilitate rapid oxidation [2,37].
In conclusion, the crucial mechanism of quinol oxidation is
still not resolved and its elucidation is a challenge for further
studies.
The structures of QCR elucidated important aspects of
structure^function relationships in these enzymes. Open ques-
tions remain concerning the interaction of the functional units
Fig. 4. Binding of the natural substrate coenzyme Q6 (UQ6) at the
Qi site of yeast QCR. A: 2Fo^Fc electron density map (blue) and
re¢ned model close to the high potential haem b. Protein model,
haem and quinone molecules are shown as stick drawings, water
molecules and the haem iron in ball representation. The quinone
ring plane is stabilized by hydrophobic interactions with Met221 of
cytochrome b and by the bend propionate A of haem bH. B: The
orientation of the quinone head group is stabilized by few polar in-
teractions with neighbouring residues. The oxygen atoms of the qui-
none carbonyl groups are located close to water molecules, suggest-
ing that the latter act as primary proton donors during ubiquinone
reduction. Atoms of the relevant amino acid residues and of UQ6
are depicted as ball-and-stick, water molecules as ball presentations.
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within the dimeric molecule, the role of tightly bound phos-
pholipid molecules, and the mechanism of quinol oxidation as
well as quinone and cytochrome c reduction.
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